Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists

Clin Adv Hematol Oncol. 2010 Nov;8(11):809-12.
No abstract available

Publication types

  • Review

MeSH terms

  • Benzoates / therapeutic use
  • Bone Marrow Diseases / drug therapy
  • Humans
  • Hydrazines / therapeutic use
  • Purpura, Thrombocytopenic / drug therapy
  • Pyrazoles / therapeutic use
  • Receptors, Fc / therapeutic use
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / therapeutic use
  • Salvage Therapy / methods
  • Thrombopoietin / therapeutic use

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim
  • eltrombopag

Supplementary concepts

  • Acquired amegakaryocytic thrombocytopenia